Our Company
Xanamem^®
Clinical Trials
Investor Centre
News
Contact Us

BACK TO NEWS

Therese Russell • 12 Jan 2023

Spark Plus Research Note
Actinogen – A company to never forget

Enjoyed this read?

Stay up to date with our latest research.

Related articles

Press Releases and Media

New magic pill to help treat Alzheimer’s disease

7 News Australia • November 16, 2024

Press Releases and Media

New breakthrough pill being trialled to combat Alzheimer’s

Sky News Australia • November 16, 2024

Press Releases and Media

Xanamem: The potential ‘Holy Grail’ for the treatment of Alzheimers

10 News Australia • November 16, 2024

Our Company
Xanamem^®

Clinical Trials

Investors
News
Contact Us
Target Market Determination

Copyright © 2024 Actinogen